Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Patent foramen ovale: Closure in young stroke patients?
Patent foramen ovale: Closure in young stroke patients?

A young woman recovers from a small stroke and questions you about percutaneous closure of a PFO. Auckland cardiologist Chris Ellis reviews the latest studies to guide your discussion
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Saver JL, Carroll JD, Thaler DE et al. for the RESPECT Investigators. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 2017;377:1022–32. DOI: 10.1056/NEJMoa1610057
2. Søndergaard L, Kasner SE, Rhodes JF et al. for the Gore REDUCE Clinical Study Investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 2017;377:1033–42. DOI: 10.1056/NEJMoa1707404
3. Mas J-L, Derumeaux G, Guillon B et al. for the CLOSE Investigators. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 2017;377:1011–21. DOI: 10.1056/NEJMoa1705915
4. Farb A, Ibrahim NG, Zuckerman BD. Patent foramen ovale after cryptogenic stroke – assessing the evidence for closure. N Engl J Med 2017;377:1006–09. DOI: 10.1056/NEJMp1700218
5. Ropper AH. Tipping point for patent foramen ovale closure [editorial]. N Engl J Med 2017;377:1093–95.